Sosei Heptares Receives Grant Funding from Wellcome to Advance the Development of Potent, Differentiated Oral Anti-Viral Small Molecules to Treat COVID-19

Funding comes through the Covid-19 Therapeutics Accelerator, which was set up by Wellcome, Bill & Melinda Gates Foundation and Mastercard TOKYO and CAMBRIDGE, United Kingdom, Dec. 7, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565) today announced it has received...

from PR Newswire: https://ift.tt/302qcTH